TRT and Sleep Apnea: Label Warning, Guidelines and Evidence

TRT and sleep apnea are connected, and the risk is real but specific. FDA labeling warns that testosterone may worsen sleep apnea in some men, especially those with obesity or chronic lung disease (FDA label, 2022). The Endocrine Society recommends against starting testosterone in untreated severe obstructive sleep apnea (Endocrine Society, 2018). In the key randomized trial, the worsening was mild and time-limited (Clinical Endocrinology, 2012).

Key takeaways

• FDA labeling for testosterone products warns that testosterone may potentiate (worsen) sleep apnea in some men, especially those with obesity or chronic lung disease (FDA label, 2022).
• The Endocrine Society recommends against starting testosterone in men with untreated severe obstructive sleep apnea (Endocrine Society, 2018), and the data on this group are limited (Frontiers in Reproductive Health, 2023).
• The best-known randomized trial in obese men with severe sleep apnea found mild worsening of nighttime breathing at 7 weeks that was no longer significant at 18 weeks (Clinical Endocrinology, 2012).
• Sleep apnea is linked to lower testosterone (Andrology, 2021), but CPAP (continuous positive airway pressure) did not significantly raise total testosterone in a meta-analysis (Frontiers in Endocrinology, 2019).
• Hematocrit is where the two risks overlap, because low oxygen from apnea and testosterone therapy are both listed causes of high red blood cell counts (AUA, 2018).

TRT and sleep apnea: can testosterone cause or worsen it?

Testosterone may worsen sleep apnea in some men, but the evidence points to a small and possibly time-limited effect. "May worsen apnea in some men" is accurate. "Causes sleep apnea" and "is safe for everyone with apnea" both overstate it.

Obstructive sleep apnea (OSA) is a condition where the upper airway repeatedly narrows or closes during sleep. This cuts airflow and lowers blood oxygen. Hypogonadism means the body makes too little testosterone.

The FDA prescribing information for a testosterone cypionate injection says that treating hypogonadal men with testosterone products may potentiate sleep apnea in some patients. It names obesity and chronic lung disease as risk factors. It also tells prescribers to counsel patients that testosterone can worsen sleep apnea (FDA label, 2022). For other recent labeling changes, see our testosterone label changes timeline.

The history is mixed. A 2021 review traces the concern to a 1978 case report and small case series. In the 1990s, a large retrospective analysis and the first randomized trial found no increase in OSA with testosterone. A later cohort study reported OSA in 16.5% of men on testosterone versus 12.7% of controls. The review concludes testosterone likely plays a small role, possibly time-limited (Sexual Medicine Reviews, 2021).

Four sources carry most of the weight:

Sleep apnea and low testosterone: how they feed each other

Sleep apnea is associated with lower testosterone, and obesity is the most evident shared link. Treating apnea with CPAP has not been shown to reliably raise testosterone.

A meta-analysis of 18 studies and 1,823 men found a significant inverse association between OSA and testosterone. It held after adjusting for age and body mass index (Andrology, 2021). An association shows the two travel together. It does not prove one causes the other.

A 2023 review calls obesity the most evident shared link and notes that about half of obese patients have OSA. It also describes how apnea itself may lower testosterone: low oxygen, more awakenings, fragmented sleep and a weaker pulse of LH (luteinizing hormone, the pituitary signal that tells the testes to make testosterone) (Frontiers in Reproductive Health, 2023).

CPAP (continuous positive airway pressure) uses a mask and pressurized air to hold the airway open. A 2019 meta-analysis of 10 cohort studies and 2 randomized trials, 388 patients in total, found CPAP was not associated with a significant change in total testosterone. The result held in men with low and normal baseline levels. The authors concluded other strategies should be considered for managing low testosterone in men with OSA (Frontiers in Endocrinology, 2019). A 2019 review agrees that apnea treatment does not reliably raise testosterone in most studies (World Journal of Men's Health, 2019).

Some clinic pages claim that treating apnea restores testosterone, or that testosterone itself helps apnea. The sources reviewed here don't support either claim. A 2021 review also notes that theories that testosterone narrows the airway or alters sleep architecture have been largely disproven, while still concluding it likely plays a small role in worsening apnea (Sexual Medicine Reviews, 2021).

What the randomized evidence on testosterone therapy and sleep apnea shows

One well-cited randomized trial found testosterone mildly worsened nighttime breathing in obese men with severe OSA at 7 weeks. By 18 weeks, the difference was not significant.

The trial was 18 weeks long, randomized, double-blind and placebo-controlled. It enrolled 67 obese men with severe OSA, all on a reduced-calorie diet, who received testosterone injections or placebo. Researchers used polysomnography, an overnight sleep study that records breathing, oxygen and sleep stages, at 0, 7 and 18 weeks (Clinical Endocrinology, 2012). The oxygen desaturation index counts how many times per hour blood oxygen drops.

The 7-week confidence interval for the desaturation index ran from 0.8 to 19.8 events per hour, so the true effect could be small or fairly large. Baseline testosterone did not change the results, and blood testosterone did not track with the breathing measures. The authors concluded that testosterone mildly worsens sleep-disordered breathing in this group, in a time-limited way (Clinical Endocrinology, 2012).

The limits matter. This is one small, short trial of one injectable regimen in dieting obese men with severe OSA. It says little about long-term use or men without OSA, and much of this evidence base is now more than a decade old.

Untreated severe sleep apnea: what the testosterone guideline says

The Endocrine Society recommends against starting testosterone in men with untreated severe OSA. That is a precautionary line for a specific group, not proof that testosterone harms every man with apnea.

The same guideline list includes elevated hematocrit, near-term fertility plans, uncontrolled heart failure and recent heart attack or stroke (Endocrine Society, 2018). For those other questions, see what the TRAVERSE trial showed about heart risk and the prostate cancer evidence.

A 2023 review notes that data on TRT in men with OSA are limited. It says testosterone in men with untreated or severe OSA should be considered with caution and on an individual basis (Frontiers in Reproductive Health, 2023). A 2019 review says TRT should probably be avoided in severe untreated OSA (World Journal of Men's Health, 2019).

Two words carry the weight:

• Untreated means apnea that is not being managed, for example diagnosed OSA without regular CPAP use.
• Severe is a sleep-study category based on the apnea-hypopnea index (AHI), the average number of breathing pauses and shallow-breathing episodes per hour. The 2023 review lists mild as 5 to 15, moderate as 15 to 30 and severe as above 30 events per hour (Frontiers in Reproductive Health, 2023).

Treated apnea changes the picture, but it doesn't make testosterone automatic. None of the guideline sources here set a fixed waiting period. A licensed clinician decides based on the full history, labs and visit.

Sleep apnea, hematocrit and testosterone: where the risks overlap

Low oxygen from sleep apnea and testosterone therapy can both raise red blood cell counts. That is why hematocrit is checked before and during therapy.

Hematocrit is the share of your blood volume made up of red blood cells. Polycythemia means too many red cells, which the AUA guideline generally defines as a hematocrit above 52%. The AUA lists hypoxia (low oxygen, including from OSA or chronic obstructive pulmonary disease (COPD)), tobacco use, high altitude and testosterone therapy as secondary causes (AUA, 2018).

The guideline thresholds clinicians work from:

• AUA: measure hemoglobin and hematocrit before therapy and inform patients of the polycythemia risk. If hematocrit is above 50%, consider withholding testosterone until the cause is investigated. On therapy, 54% or higher warrants intervention, meaning a clinician may adjust or pause the plan (AUA, 2018).
• Endocrine Society: don't start testosterone with a baseline hematocrit above the lab's upper limit without discussing the risk and close monitoring, and include hematocrit in ongoing monitoring (Endocrine Society, 2018).

A 2023 review proposes OSA as a risk factor for secondary polycythemia that testosterone might make worse, and discusses sleep testing for men who develop apnea signs during therapy (Frontiers in Reproductive Health, 2023). These are thresholds clinicians act on, not targets to manage yourself. For the full schedule, see our TRT blood work and monitoring guide.

Does the form of testosterone matter for sleep apnea risk?

Possibly, but no head-to-head trial compares forms on apnea outcomes. What exists points to differences in red blood cell effects and dosing intensity.

The AUA says polycythemia rates by form can't be precisely determined, but trials show injectable testosterone is associated with the largest rises in hemoglobin and hematocrit (AUA, 2018). The Endocrine Society tells clinicians to weigh formulation-specific adverse effects and patient preference (Endocrine Society, 2018). The 2023 review suggests short-term high-dose testosterone might worsen OSA, while longer-term lower exposure could eventually be associated with symptom improvement (Frontiers in Reproductive Health, 2023). That is the review's interpretation, not an established finding.

No form has been shown to be "safe for apnea." Choosing a form, if any, is a clinical decision.

Sleep symptoms to raise before starting testosterone

Tell your clinician about any sign of disrupted breathing at night, plus prior sleep testing and lab history. Many OSA symptoms overlap with low testosterone symptoms, so they are easy to miss.

The 2023 review lists OSA symptoms including snoring, nighttime urination, daytime sleepiness, morning headache, trouble concentrating, reduced libido, irritability and low mood (Frontiers in Reproductive Health, 2023). Bring up:

• Snoring, especially loud or nightly
• Breathing pauses a partner has noticed
• Waking up gasping or choking
• Daytime sleepiness or morning headaches
• Any past sleep study and its result
• CPAP or oral appliance use, and how consistently you use it
• Chronic lung disease
• Any past high hematocrit or hemoglobin

The FDA Medication Guide asks patients to tell their provider about sleep apnea and high red blood cell counts (FDA label, 2022). After starting, report new or worse snoring, daytime sleepiness or witnessed pauses. A 2019 review advises asking about OSA symptoms both before and after starting (World Journal of Men's Health, 2019). If you have severe trouble breathing, chest pain or stroke symptoms, seek emergency care.

How access works through New Blue

New Blue is a technology and administrative services platform. Medical services are provided by independent licensed clinicians; medications are dispensed only if prescribed.

1. Complete an intake that covers your medical history, including sleep symptoms and any apnea diagnosis or CPAP use.
2. Attend a live clinician visit and complete lab work. Every testosterone pathway is synchronous.
3. A licensed clinician decides whether treatment is appropriate. They may want a sleep evaluation or apnea treatment in place first.
4. If prescribed, a licensed partner pharmacy ships the medication directly to you.

Injectable, cream and oral testosterone protocols are available, all with a live visit and labs. Which form fits, if any, is a clinician's decision. Not everyone qualifies. Eligibility depends on your intake and clinical review, and that's how it should work. For current pricing, see the injectable testosterone protocol page.

Availability varies by state; check state availability. Adults 21+ only. Not for emergencies. Consultation timing varies by clinician availability. If treatment isn't appropriate, refunds follow our refund policy. New Blue is LegitScript certified.

Frequently Asked Questions

Can I start TRT if I already use CPAP?

Possibly, but it isn't automatic. The Endocrine Society's recommendation against starting testosterone applies to untreated severe obstructive sleep apnea, and consistently treated apnea is a different situation. A licensed clinician makes the decision based on your sleep history, labs and the live visit.

Will testosterone therapy fix my sleep apnea?

No source reviewed here supports testosterone as a sleep apnea treatment. FDA labeling warns that testosterone may potentiate sleep apnea in some men, especially those with obesity or chronic lung disease. A 2023 review describes CPAP as the treatment of choice for obstructive sleep apnea.

Will CPAP raise my testosterone levels?

Probably not reliably. A 2019 meta-analysis of 388 patients found CPAP was not associated with a significant change in total testosterone, including in men who started with low levels. Sleep apnea treatment matters for its own reasons, but it isn't a dependable way to restore testosterone.

Is the breathing worsening from testosterone permanent?

In the best-known randomized trial, breathing measures worsened mildly at 7 weeks, and the differences were not significant at 18 weeks. That trial was small, short and limited to obese men with severe apnea who were dieting. It can't tell you how any one man will respond over the long term.

Why does my clinician care about hematocrit when my question is about sleep?

Low oxygen from sleep apnea and testosterone therapy can both raise red blood cell counts. The AUA guideline lists both as causes of secondary polycythemia and recommends checking hematocrit before therapy. A high reading can prompt a clinician to look for an underlying cause such as apnea.

Do I need a sleep study before starting TRT?

The sources reviewed here don't set a universal sleep-study requirement before testosterone. A clinician may suggest one based on symptoms, risk factors such as obesity, or lab results. A 2023 review also discusses sleep testing for men who develop apnea signs during therapy.

Sources

1. Testosterone Cypionate Injection, prescribing information (NDA 216318). U.S. Food and Drug Administration, 2022. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/216318s000lbl.pdf
2. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology and Metabolism, 2018. https://pubmed.ncbi.nlm.nih.gov/29562364/
3. Evaluation and Management of Testosterone Deficiency: AUA Guideline. Journal of Urology, 2018. https://doi.org/10.1016/j.juro.2018.03.115
4. Effects of testosterone therapy on sleep and breathing in obese men with severe obstructive sleep apnoea: a randomized placebo-controlled trial. Clinical Endocrinology, 2012. https://pubmed.ncbi.nlm.nih.gov/22512435/
5. The complex relation between obstructive sleep apnoea syndrome, hypogonadism and testosterone replacement therapy. Frontiers in Reproductive Health, 2023. https://pubmed.ncbi.nlm.nih.gov/37881222/
6. Obstructive Sleep Apnea and Testosterone Deficiency. The World Journal of Men's Health, 2019. https://pubmed.ncbi.nlm.nih.gov/29774669/
7. Association between obstructive sleep apnea and male serum testosterone: A systematic review and meta-analysis. Andrology, 2021. https://doi.org/10.1111/andr.13111
8. Effects of CPAP on Testosterone Levels in Patients With Obstructive Sleep Apnea: A Meta-Analysis Study. Frontiers in Endocrinology, 2019. https://pmc.ncbi.nlm.nih.gov/articles/PMC6712440/
9. Obstructive Sleep Apnea and Testosterone Therapy. Sexual Medicine Reviews, 2021. https://doi.org/10.1016/j.sxmr.2020.04.004

Medical disclaimer: This article is for educational purposes only and is not medical advice. Decisions about testosterone therapy, sleep apnea evaluation and any treatment are made by a licensed clinician based on your history, labs and clinical review. New Blue Health is a technology and administrative services platform, not a medical provider.